Still no timeline for launch of Canada’s overdue Cannabis Act review

By Solomon Israel – June 29, 2022 

The Canadian government still has no publicly projected launch date for its mandatory review of the country’s 2018 recreational cannabis legalization law, more than eight months after the reappraisal was due to begin.

The delayed review is holding back progress toward much-needed regulatory reforms for Canada’s legal cannabis industry, according to one industry executive.

“There’s a lot that needs to be done with the legislative review,” Rick Savone, senior vice president of global government relations at Alberta-based Aurora Cannabis and chair of the industry group Cannabis Council of Canada, told MJBizDaily.

“And because that’s being held up, very little is getting done from a regulatory or from a legislative perspective.”

The review, which will result in a report to parliament, was supposed to begin by October 2021, three years after Canada legalized recreational cannabis.

However, MJBizDaily reported in February that the review had not yet begun.

Four months later, Health Canada still will not provide MJBizDaily with a timeline for when the review would begin.

A Health Canada spokesperson reiterated the federal department’s previous statement, describing the upcoming review as a “credible, evidence-driven process.

“Preparations are underway for the launch of the legislative review,” the spokesperson said via email.

In the meantime, Canada’s legal cannabis industry is waiting for the review to get underway – and even once it starts, it could last as long as 18 months, according to the 2018 cannabis legislation.

“All of the players are waiting to see what happens with the statutory review to be able to make the improvements that are required. I think there’s almost a consensus about what needs to be done for the sector,” Aurora’s Savone said.

“So we’re stuck waiting. And every day we wait, our competitors, especially our global competitors, get better positioned in this market.”

Canadian cannabis industry players previously told MJBizDaily that they want to use the review as a forum to address issues including:

  • Marketing and advertising restrictions.
  • Cannabis edibles potency limits.
  • Government regulatory fees.
  • Cannabis excise taxes.

Industry insiders say they plan to address several of the same issues through an upcoming cannabis roundtable that will bring together government officials and industry leaders.

Read the entire article here